PubMed HealthSearch

Biomedical subjects

K Heydon

Publications and source records attributed to K Heydon.

4 recordsLinked to original sources

In sympathetic but not sensory neurones, phosphoinositide-3 kinase is important for NGF-dependent survival and the retrograde transport of 125I-betaNGF.

The way in which the same ligands and receptors have different functional effects in different cell types must depend on subtle differences in the second messenger cascades. Sensory and sympathetic neurones both retrogradely transport nerve growth factor (NGF) and depend on NGF for their developmental survival. NGF binding to the high affinity tyrosine kinase (TrkA) receptors initiates second messenger signalling cascades, one of which includes the activation of phosphoinositide-3 kinase (PI3-kinase). We demonstrate that 100-fold higher concentrations of the PI3-kinase inhibitor, Wortmannin, are required to inhibit the survival effects and retrograde axonal transport of NGF in sensory neurones than in sympathetic neurones. Similarly, although less potently than Wortmannin, the PI3-kinase inhibitor LY294002 required a 10-fold higher concentration to inhibit the survival effects of NGF in sensory than in sympathetic neurones. Inhibitors of other second messengers, including staurosporine, pertussis and cholera toxins, failed to have an effect on the transport of the NGF receptor complex in both cell types. Also, Wortmannin did not affect the structural integrity of the sympathetic nerve terminals. As PI3-kinase is present in both neuronal populations, this suggests that the Wortmannin sensitive isoform of PI3-kinase (p110) is essential in sympathetic neurones both for survival and for NGF-TrkA receptor complex trafficking. As sensory neurones also depend on NGF for their developmental survival and endocytose and retrogradely transport the NGF-TrkA receptor complex, this population of neurones may either recruit a different isoform of PI3-kinase or utilize PI3-kinase independent signalling pathways for these cellular functions.

1-Phosphatidylinositol 4-Kinase

Retrograde axonal transport of the alpha subunit of the GTP-binding protein Gz to the nucleus of sensory neurons.

Nerve cells are exquisitely sensitive to target tissue derived factors and the discovery that nerve growth factor could be retrogradely transported in axons suggested that the physical translocation of proteins along the axon could be a mechanism to convey this signal. This message is not due to the neurotrophic factor itself but rather due to second messengers generated by interaction with receptors. We have previously demonstrated the retrograde axonal transport of the alpha subunits of two putative second messenger molecules Gi and Gz. We have investigated more thoroughly the transport of the alpha subunit of Gz (Gz alpha) and in order to be more certain that the immunoreactivity seen is due to Gz alpha, we have made antibodies to peptides from both the N- and C-terminal regions of Gz alpha, which recognise the same 41 kDa band on Western blots of brain and sciatic nerve extracts. This band is eliminated when the antibodies are previously incubated with the specific peptide to which they were made. Using these antibodies for immunohistochemical localisation for Gz alpha, we now report that the GTP-binding protein Gz, is not only retrogradely transported in axons but that it translocates to the neuronal nucleus. Furthermore, the levels seen in the nuclear compartment decline after axotomy or ligation of the mice under ether anaesthetic, suggesting it is the retrogradely transported Gz alpha that is accumulating in the nucleus after activation at the nerve terminal.

Amino Acid Sequence

Developmental signalling.

1. In investigating the communication paths between target tissue and neurons we have been led to propose two classes of neurotrophic factors. One comprises the factors which transport themselves, the other factors relying on the transport of a second messenger. The former may have labile second messenger systems necessitating the translocation of agonist and receptor from the nerve terminal to the cell body and the latter must possess a stable second messenger system that itself is sufficiently robust to survive the transport to the cell body. 2. One such class of stable messengers may be the GTP-binding protein family and it has been shown that the alpha subunits of both Gi alpha and Gz alpha can be retrogradely transported in the mouse sciatic nerve. 3. Examination of the cell bodies in the dorsal root ganglia revealed that Gz alpha accumulated in the nucleus of cells with intact axons but that 24 h after axonal ligation this immunoreactivity decreased. 4. It is suggested that Gz is activated at the nerve terminal and it, or at least its alpha subunit, undergoes retrograde transport to the cell body where it accumulates in the nucleus.

Animals

Retrograde axonal transport of the alpha-subunit of the GTP-binding protein GZ in mouse sciatic nerve: a potential pathway for signal transduction in neurons.

We have utilized antibodies against the alpha subunit of GZ in fluorescence immunohistochemistry to determine whether this GTP-binding protein can translocate along nerves by intra-axonal transport. After ligation of the mouse sciatic nerve we found an increase in GZ-like immunoreactivity on the proximal and distal side with time, suggesting that the alpha subunit undergoes orthograde axonal transport and also returns to the cell body by retrograde axonal transport in the sciatic nerve. Unlike the retrograde transport of Gi alpha, shown in a previous study to be present in most sciatic axons, GZ alpha only accumulated in a subpopulation of axons, suggesting that different G-proteins could convey information specific to neuronal subtypes. These results support our proposal that GZ may play a second messenger role in communicating information from the terminals back to cell bodies. Gi alpha and GZ alpha may be representative of relatively stable signalling molecules by which the signal from some neurotrophic molecules can be translocated from the neuron periphery to the cell body without the need for the retrograde transport of the neurotrophic factor itself.

Amino Acid Sequence